Hemorrhoids-Pipeline Insight, 2021 | Analytical Research Cognizance

Hemorrhoids-Pipeline Insight, 2021

Published by ARCDI001
Report ID 1667935
Published date Mar 30, 2021
Category Pharmaceuticals and Healthcare
Total Pages 60
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

DelveInsight’s, “Hemorrhoids- Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hemorrhoids pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered
Global coverage

Hemorrhoids Understanding
Hemorrhoids: Overview
Hemorrhoids, also called piles, are swollen and inflamed veins around the anus or in lower rectum. External hemorrhoids form under the skin around the anus. Internal hemorrhoids form in the lining of the anus and lower rectum. Symptoms of hemorrhoids depend on the type of hemorrhoid. External hemorrhoid symptoms include anal itching. Internal hemorrhoid symptoms include rectal bleeding. Certain toilet habits, constipation, a low-fiber diet, and aging may cause hemorrhoids.

"Hemorrhoids - Pipeline Insight, 2021" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Hemorrhoids pipeline landscape is provided which includes the disease overview and Hemorrhoids treatment guidelines. The assessment part of the report embraces, in depth Hemorrhoids commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Hemorrhoids collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights
The companies and academics are working to assess challenges and seek opportunities that could influence Hemorrhoids R&D. The therapies under development are focused on novel approaches to treat/improve Hemorrhoids.

Hemorrhoids Emerging Drugs Chapters
This segment of the Hemorrhoids report encloses its detailed analysis of various drugs in different stages of clinical development, including phase III, II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Hemorrhoids Emerging Drugs
CITI-002: Citius Pharmaceuticals
CITI-002 is a topical formulation of halobetasol and lidocaine that is intended to provide anti-inflammatory and anesthetic relief to individuals suffering from hemorrhoids. Citius’ halobetasol and lidocaine formulation could become the first FDA-approved product to treat hemorrhoids in the United States.
Further product details are provided in the report……..

Hemorrhoids: Therapeutic Assessment
This segment of the report provides insights about the different Hemorrhoids drugs segregated based on following parameters that define the scope of the report, such as:
Major Players in Hemorrhoids
There are approx. 10+ key companies which are developing the therapies for Hemorrhoids. The companies which have their Hemorrhoids drug candidates in the most advanced stage, i.e. Phase II include, Citius Pharmaceuticals.

Phases
DelveInsight’s report covers around 10+ products under different phases of clinical development like
Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates

Route of Administration
Hemorrhoids pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Oral
Parenteral
Intravitreal
Subretinal
Topical

Molecule Type
Products have been categorized under various Molecule types such as
Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy

Product Type
Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Hemorrhoids: Pipeline Development Activities
The report provides insights into different therapeutic candidates in phase III, II, I, preclinical and discovery stage. It also analyses Hemorrhoids therapeutic drugs key players involved in developing key drugs.
Pipeline Development Activities
The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Hemorrhoids drugs.

Hemorrhoids Report Insights
Hemorrhoids Pipeline Analysis
Therapeutic Assessment
Unmet Needs
Impact of Drugs

Hemorrhoids Report Assessment
Pipeline Product Profiles
Therapeutic Assessment
Pipeline Assessment
Inactive drugs assessment
Unmet Needs

Key Questions
Current Treatment Scenario and Emerging Therapies:
How many companies are developing Hemorrhoids drugs?
How many Hemorrhoids drugs are developed by each company?
How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Hemorrhoids?
What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Hemorrhoids therapeutics?
What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
What are the clinical studies going on for Hemorrhoids and their status?
What are the key designations that have been granted to the emerging drugs?

Key Players
Pacira Pharmaceuticals, Inc
Peritech Pharma Ltd.
Ventrus Biosciences, Inc
Nivagen Pharmaceuticals Inc.
Citius Pharmaceuticals, Inc.
Panacea Biotec Ltd

Key Products
SKY0402
PP110 Gel
Iferanserin
Hydrocortisone Acetate Suppository, 25 mg
Hydrocortisone acetate and lidocaine hydrochloride
Euphorbia tablets

Introduction
Executive Summary
Hemorrhoids: Overview
Causes
Mechanism of Action
Signs and Symptoms
Diagnosis
Disease Management
Pipeline Therapeutics
Comparative Analysis
Therapeutic Assessment
Assessment by Product Type
Assessment by Stage and Product Type
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Hemorrhoids – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Hemorrhoids companies’ collaborations, Licensing, Acquisition -Deal Value Trends
Hemorrhoids Collaboration Deals
Company-Company Collaborations (Licensing / Partnering) Analysis
Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
Comparative Analysis
Drug Name: Company Name
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Comparative Analysis
CITI-001: Citius Pharmaceuticals
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
Comparative Analysis
Drug Name: Company Name
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Comparative Analysis
Drug Name: Company Name
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
Comparative Analysis
Hemorrhoids Key Companies
Hemorrhoids Key Products
Hemorrhoids- Unmet Needs
Hemorrhoids- Market Drivers and Barriers
Hemorrhoids- Future Perspectives and Conclusion
Hemorrhoids Analyst Views
Hemorrhoids Key Companies
Appendix

Table 1 Total Products for Hemorrhoids
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products
Figure 1 Total Products for Hemorrhoids
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products